Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Wedelolactone Targets EZH2-mediated Histone H3K27 Methylation in Mantle Cell Lymphoma

NADEZHDA ROMANCHIKOVA and PETERIS TRAPENCIERIS
Anticancer Research August 2019, 39 (8) 4179-4184; DOI: https://doi.org/10.21873/anticanres.13577
NADEZHDA ROMANCHIKOVA
Latvian Institute of Organic Synthesis, Riga, Latvia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nadezhda.romanchikova{at}gmail.com
PETERIS TRAPENCIERIS
Latvian Institute of Organic Synthesis, Riga, Latvia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Histone methyltransferase (HMT) activity for methylation of histone H3 at lysine 27 in nuclear extracts (NE) from Mino cells exposed in reaction with different concentrations of Wedelolactone, compared to untreated NE (C). The data are presented as mean±SD. No statistical significance was found.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Histone methyltransferase (HMT) activity for methylation of histone H3 at lysine 27 in nuclear extracts (NE) from Mino cells cultivated with different concentrations of Wedelolactone for 24 h compared to untreated NE (C). The data are presented as mean±SD. *p<0.05 (compared to control).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Percentage of histone 3 lysine 27 (H3K27) methylation activity of the PRC2 complex (EZH2/EED/SUZ12/RbAp48/AEBP) exposed in reaction with or without Wedelolactone in control (C). The data are presented as meanσ±SD. **p<0.01 (compared to control).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    EZH2 amount measured in nuclear extracts from Mino cells treated with Wedelolactone (0.1, 1.0, 3.0, and 7.5 μM) or untreated (C). The data are presented as mean±SD. *p<0.05 (compared to control).

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Summary of the effects of Wedelolactone treatment on histone 3 lysine 27 (H3K27) histone methyltransferase (HMT) activity, EZH2 amount, and cytotoxicity (in percent) in Mino cells treated with 0.1, 1.0, 3.0, and 7.5 μM of Wedelolactone in comparison to untreated cells (C). The data are presented as mean±SD.

Tables

  • Figures
  • Table I.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 39, Issue 8
August 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Wedelolactone Targets EZH2-mediated Histone H3K27 Methylation in Mantle Cell Lymphoma
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Wedelolactone Targets EZH2-mediated Histone H3K27 Methylation in Mantle Cell Lymphoma
NADEZHDA ROMANCHIKOVA, PETERIS TRAPENCIERIS
Anticancer Research Aug 2019, 39 (8) 4179-4184; DOI: 10.21873/anticanres.13577

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Wedelolactone Targets EZH2-mediated Histone H3K27 Methylation in Mantle Cell Lymphoma
NADEZHDA ROMANCHIKOVA, PETERIS TRAPENCIERIS
Anticancer Research Aug 2019, 39 (8) 4179-4184; DOI: 10.21873/anticanres.13577
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Ginsenoside Rd Improves Anticancer Drug-induced Disturbance in Murine Airway Ciliary Motility
  • Association of Matrix Metalloproteinase-11 Genotypes With Taiwan Gastric Cancer Risk and Clinical Features
  • Methionine Restriction, Not Cysteine Restriction, Is a Cancer-specific Vulnerability
Show more Experimental Studies

Keywords

  • EZH2
  • H3K27 methylation
  • Mantle cell lymphoma
  • wedelolactone
  • PRC2
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire